Cargando…

Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans

To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Lina, Aubrecht, Jiri, Li, Dingzhou, Warner, Roscoe L., Johnson, Kent J., Kenny, Julia, Colangelo, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841799/
https://www.ncbi.nlm.nih.gov/pubmed/29513725
http://dx.doi.org/10.1371/journal.pone.0193824
_version_ 1783304800179322880
author Luo, Lina
Aubrecht, Jiri
Li, Dingzhou
Warner, Roscoe L.
Johnson, Kent J.
Kenny, Julia
Colangelo, Jennifer L.
author_facet Luo, Lina
Aubrecht, Jiri
Li, Dingzhou
Warner, Roscoe L.
Johnson, Kent J.
Kenny, Julia
Colangelo, Jennifer L.
author_sort Luo, Lina
collection PubMed
description To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to be biomarkers of liver injury for decades, and more recently, monitoring of IBA has been proposed for differentiation of variety of etiologies of liver injury. We established a LC-MS/MS methodology to analyze nine IBA, generated reference ranges, and examined effects of age, gender, and ethnicity for each IBA. Furthermore, we evaluated the ability of IBA and their profiles to detect hepatic injury in subjects with a broad range of liver impairments. To date, our study utilized the largest total cohort of samples (N = 645) that were divided into 2 groups, healthy or liver impaired, to evaluate IBA as biomarkers. The TBA serum levels in the Asian ethnic group trended higher when compared to other ethnic groups, and the serum concentrations of IBA, such as glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), chenodeoxycholic acid (CDCA), and taurochenoxycholic acid (TCDCA) were significantly increased. To our knowledge, this report is the first to describe ethnic differences in serum concentrations of IBAs. In patients with hepatic impairments, with the exception of deoxycholic acid (DCA), the concentrations of IBAs were significantly elevated when compared with healthy subjects. The conjugated bile acids displayed greater differences between healthy subjects and subjects with hepatic impairments than non-conjugated bile acids. Furthermore, the subjects with hepatic impairments exhibited distinct profiles (signatures) of IBAs that clustered subjects according the nature of their liver impairments. Although additional studies are needed, our data suggested that the analysis of IBA has the potential to become useful for differentiation of various forms of liver injury.
format Online
Article
Text
id pubmed-5841799
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-58417992018-03-23 Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans Luo, Lina Aubrecht, Jiri Li, Dingzhou Warner, Roscoe L. Johnson, Kent J. Kenny, Julia Colangelo, Jennifer L. PLoS One Research Article To assess the potential of individual bile acids (IBA) and their profiles as mechanistic biomarkers of liver injury for humans in real world situations, we interrogated samples collected under minimum controlled conditions (ie subjects were not fasted). Total bile acids (TBA) have been considered to be biomarkers of liver injury for decades, and more recently, monitoring of IBA has been proposed for differentiation of variety of etiologies of liver injury. We established a LC-MS/MS methodology to analyze nine IBA, generated reference ranges, and examined effects of age, gender, and ethnicity for each IBA. Furthermore, we evaluated the ability of IBA and their profiles to detect hepatic injury in subjects with a broad range of liver impairments. To date, our study utilized the largest total cohort of samples (N = 645) that were divided into 2 groups, healthy or liver impaired, to evaluate IBA as biomarkers. The TBA serum levels in the Asian ethnic group trended higher when compared to other ethnic groups, and the serum concentrations of IBA, such as glycocholic acid (GCA), glycochenodeoxycholic acid (GCDCA), chenodeoxycholic acid (CDCA), and taurochenoxycholic acid (TCDCA) were significantly increased. To our knowledge, this report is the first to describe ethnic differences in serum concentrations of IBAs. In patients with hepatic impairments, with the exception of deoxycholic acid (DCA), the concentrations of IBAs were significantly elevated when compared with healthy subjects. The conjugated bile acids displayed greater differences between healthy subjects and subjects with hepatic impairments than non-conjugated bile acids. Furthermore, the subjects with hepatic impairments exhibited distinct profiles (signatures) of IBAs that clustered subjects according the nature of their liver impairments. Although additional studies are needed, our data suggested that the analysis of IBA has the potential to become useful for differentiation of various forms of liver injury. Public Library of Science 2018-03-07 /pmc/articles/PMC5841799/ /pubmed/29513725 http://dx.doi.org/10.1371/journal.pone.0193824 Text en © 2018 Luo et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Luo, Lina
Aubrecht, Jiri
Li, Dingzhou
Warner, Roscoe L.
Johnson, Kent J.
Kenny, Julia
Colangelo, Jennifer L.
Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
title Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
title_full Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
title_fullStr Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
title_full_unstemmed Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
title_short Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
title_sort assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841799/
https://www.ncbi.nlm.nih.gov/pubmed/29513725
http://dx.doi.org/10.1371/journal.pone.0193824
work_keys_str_mv AT luolina assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans
AT aubrechtjiri assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans
AT lidingzhou assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans
AT warnerroscoel assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans
AT johnsonkentj assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans
AT kennyjulia assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans
AT colangelojenniferl assessmentofserumbileacidprofilesasbiomarkersofliverinjuryandliverdiseaseinhumans